the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Apoptosis: Promise or Deception?

Published by BioSeeker Group AB Contact us : +1-860-674-8796
Published 2005/05 Content info 85 pages
Product code BG29543
Price From  US $ 1365 Order/Price list
US $ 1365 PDF by E-mail (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

Apoptosis: Promise or deception?

Table of Contents

BSG General Working Model & Methodology

Key findings

Introduction

  • Figure 1. Generalized illustration, depicting the key elements involved in the apoptotic pathways.
  • Table 1. Common gene/protein defects in apoptotic pathways and associated mechanism

Multipathway Regulators

  • Table 2 Overview of Apoptosis Targets Under Development

Projects on the p53 Pathway Increasing Again

  • Box 1. The Agreement Between Sanofi-Aventis and Introgen Therapeutics
  • Table 3. Overview of p53 Based Therapies in Clinical Trial
  • New Attention to p53 Gene Therapy
  • Activating p53 with Small-Molecule Drugs
  • Are p53-MDM2 interacting peptides the future?
  • Will 2nd generation of antisense that targets mdm2 deliver?
  • Drug discovery to develop inhibitors of the p53-MDM2 interaction
  • The importance of Aurora Kinase inhibitors

The Bcl-2 Pathway: Antisense versus New Approaches

  • Table 4. Overview of Bcl-2 and Bcl-XL Based Therapies in Clinical Trial
  • Has Genasense Lost its Sting?
  • Box 2 The Collaboration Between Genta and Aventis
  • Improved Bcl-2 Antisense Takes Off
  • Peptides and Small Molecules Mimics: Option to Bcl-2 Antisense
  • Other Drugs Mediating a Bcl-2 Pathway-Induced Cell Death

Death Receptors a Powerful Way To Apoptosis

  • Table 5. Overview of Death Receptor Based Therapies in Clinical Trial
  • Monoclonal Antibodies Towards TRAIL Receptor: Expanded Clinical Trials
  • A Soluble Form of TRAIL Finally in Phase I trial
  • Attempts Made for Fas Ligand System

Time Ripe for Inhibitors of Apoptosis Proteins

  • Table 6. Overview of IAP Based Therapies in Clinical Trial
  • Way Around Drug Resistance
  • Survivin: Cell Death Inhibitor Or Not? Still an Excellent Target
  • Smac/Diablo: Peptides and Small Molecule Mimetics

Modulators of the Caspase Pathway on Way

  • Table 7. Overview of Caspase Based Therapies in Clinical Trial
  • Companies with Focus on Caspase
  • Newly Discovered Compound Affecting the Activity of Caspases

Appendix A Company Profiles

Abbreviation List

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.